Skip to main content

Table 4 Summary of dose of carbamazepine and therapy adherence of TN patients

From: The serotonin transporter gene polymorphism is associated with the susceptibility and the pain severity in Idiopathic Trigeminal Neuralgia patients

Dose

Treatment without improvement

Treatment with improvement

P

400 mg/day

34

55

0.620

800 mg/day

33

71

 

>800 mg/day

9

15

 

Discontinuation due to side effect

11

6

0.568

Discontinuation due to interventional or surgical treatment

6

4

0.448